Le Lézard
Classified in: Science and technology
Subjects: Survey, Award

Nucleus Research Releases 2023 ROI Awards Recognizing Year's Top Technology Deployments


Nucleus Research has announced the winners of the 2023 ROI Awards. Each year, Nucleus recognizes the year's top enterprise technology implementations based on the overall value delivered by each solution. Independent ROI assessment calculations of the actual business benefits and ROI achieved by each project were conducted by analysts at Nucleus Research. The top 10 winners were selected from hundreds of IT project nominations submitted by corporations, non-profits, governmental and educational organizations.

"The constantly changing economy has highlighted the importance of investing in technology that delivers the best value for your unique operational environment," said Ian Campbell, CEO of Nucleus Research. "This year's ROI award winners prove that investments in technology can both return dramatic value and open opportunities for new products and customer expansion."

The following deployments were recognized as ROI Award winners:

To learn more about the ROI Awards, click here.

About Nucleus Research 
Nucleus Research is the recognized global leader in ROI technology research. Using a case-based approach, we provide research streams and advisory services that allow vendors and end users to quantify and maximize the return from their technology investments. For more information, visit NucleusResearch.com or follow our latest updates on LinkedIn.


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: